What makes an SCC high-risk and more likely to spread? 

While the majority of squamous cell carcinomas are successfully treated with local surgery, a specific subset is classified by clinicians as high-risk due to a greater probability of returning or spreading to other parts of the body. In the United Kingdom, dermatologists and surgeons use established criteria to identify these aggressive tumours early in the diagnostic process. This classification is vital because it determines how extensively a patient must be treated and how closely they need to be monitored in the following years. Factors such as the size of the growth, its specific location on the body, and the way the cells appear under a microscope all contribute to the overall clinical risk profile. 

What We’ll Discuss in This Article 

• Clinical definitions of tumour size and depth of invasion 

• High-risk anatomical locations on the face and extremities 

• Histological features and the importance of cell differentiation 

• Perineural invasion and its impact on cancer spread 

• Patient-related factors including immunosuppression 

• How high-risk status influences NHS treatment pathways 

Tumour size and the depth of invasion 

The physical dimensions of a squamous cell carcinoma are among the most significant indicators of its potential to spread. Clinically, any lesion with a diameter greater than two centimetres is considered to be at a higher risk of metastasis. As a tumour grows larger on the surface, it is statistically more likely to have developed the biological mechanisms required to invade deeper into the structural layers of the skin. 

The National Health Service explains that while most squamous cell carcinomas stay in the top layer of the skin for some time, they can grow deeper and spread to other parts of the body if they are not caught early. The depth of invasion, often measured in millimetres from the surface, is a critical measurement provided in a pathology report. A tumour that has invaded beyond the subcutaneous fat layer or has a thickness of more than six millimetres carries a significantly higher risk of involving local lymph nodes. These measurements help the multidisciplinary team decide if further scans or more extensive surgery are required to ensure patient safety. 

High-risk anatomical locations 

The location of a squamous cell carcinoma plays a major role in its clinical classification. Certain areas of the body are associated with a higher rate of recurrence and spread, often because the skin is thinner or the area has a rich network of lymph vessels. High-risk sites include the ears, the hair-bearing scalp, and the central features of the face such as the nose and the lips. Cancers in these locations can quickly reach deeper structures like cartilage or bone. 

NICE clinical guidelines specify that tumours located on the lip or the ear are particularly high-risk and should be managed by specialist teams to prevent local invasion or spread to the neck. Lesions arising in areas of chronic injury, such as old burn scars or long-standing ulcers, are also classified as high-risk. These are sometimes referred to as Marjolin ulcers and tend to behave more aggressively than those caused solely by sun exposure. Identifying a lesion in one of these sensitive zones ensures that it is prioritised for a prompt surgical review and definitive treatment. 

Histological features and cell differentiation 

When a pathologist examines a skin sample under a microscope, they assess the degree of differentiation, which describes how much the cancer cells still resemble normal skin cells. A well-differentiated tumour looks very similar to healthy tissue and generally grows more slowly. However, a poorly differentiated or undifferentiated tumour consists of cells that have lost their normal appearance and are often much more aggressive and likely to spread. 

The presence of specific histological patterns, such as acantholytic or spindle-cell variants, also increases the risk level. These patterns indicate that the cancer cells have undergone significant genetic changes that allow them to move through the tissue more easily. By reviewing these microscopic details, clinicians can predict the biological behaviour of the cancer. A report showing poorly differentiated cells will often lead to a recommendation for wider surgical margins or additional treatments like radiotherapy to ensure no microscopic extensions of the cancer remain. 

Perineural invasion and nerve involvement 

Perineural invasion is a high-risk feature where the cancer cells begin to grow along the paths of local nerves. This is a particularly concerning finding because nerves provide a low-resistance pathway for the cancer to travel far beyond the visible borders of the original lump. This process can sometimes cause symptoms such as tingling, numbness, or a crawling sensation on the skin, although it is often only discovered during the microscopic examination of the tissue. 

If a pathology report confirms the presence of perineural invasion, the cancer is automatically classified as high-risk. This finding suggests that the tumour is more likely to return in the same spot or spread to the regional lymph nodes. In the United Kingdom, such cases are often managed with Mohs micrographic surgery or may require adjuvant radiotherapy after the initial operation. This additional level of care is essential for halting the progression of the cancer along the nerve sheath and protecting the patient’s long-term health. 

The impact of patient-related risk factors 

The health and immune status of the patient are vital considerations in the risk assessment of squamous cell carcinoma. Individuals with a weakened immune system, such as organ transplant recipients or those with chronic lymphocytic leukaemia, are at a much higher risk of developing aggressive tumours. In these patients, the body’s natural surveillance system is less able to detect and destroy abnormal cells, allowing cancers to grow and spread more rapidly than they would in a person with a standard immune response. 

Because of this increased biological vulnerability, even small tumours in immunocompromised patients are often managed with a higher level of clinical suspicion. These patients frequently develop multiple primary tumours and require lifelong specialist monitoring. By recognising the impact of the patient’s underlying health, the NHS can provide tailored care that accounts for the higher probability of metastasis and ensures that any new lesions are identified at the earliest, most curable stage. 

Conclusion 

A high-risk squamous cell carcinoma is defined by factors such as a diameter over two centimetres, a deep level of invasion, and locations on the ears or lips. Histological signs like poor differentiation and perineural invasion also indicate a higher likelihood of the cancer spreading. Understanding these clinical markers allows specialist teams to provide more intensive treatment and closer follow-up for those at the greatest risk. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article is designed to provide clear and factual information regarding skin health for the general public. The content is written by the Medical Content Team and has been reviewed by Dr. Stefan Petrov. He is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.